Quantcast
Channel: BioTuesdays » NASDAQ:ROSG
Browsing latest articles
Browse All 3 View Live

Image may be NSFW.
Clik here to view.

Finding the origins of cancer with Rosetta Genomics

Taking its name from the Rosetta Stone, which paved the way to decipher ancient Egyptian hieroglyphics, Rosetta Genomics (NASDAQ:ROSG) is unlocking the relevance of microRNA within the human genome to...

View Article



Image may be NSFW.
Clik here to view.

Rosetta Genomics in pact for thyroid cancer diagnostic

Rosetta Genomics (NASDAQ:ROSG) has initiated a new public-private translational research project with the Institute of Molecular Translational Medicine (IMTM) at Palacky University, Olomouc, Czech...

View Article

Image may be NSFW.
Clik here to view.

Cantor upgrades Rosetta Genomics to buy

Cantor Fitzgerald has upgraded Rosetta Genomics (NASDAQ:ROSG) to “buy” from “hold” and raised its price target to $5.50 from $4, following the company’s acquisition of PersonalizeDx (PDx) from Abbott....

View Article
Browsing latest articles
Browse All 3 View Live




Latest Images